Open Access · CC BY-NC-ND 3.0
The clinical potential of proteasome inhibition
European Journal of Cancer Supplements · 2004
DOI: 10.1016/j.ejcsup.2004.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer Supplements, 2004. Verfasst von Kenneth C. Anderson. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderson, K. C. (2004). The clinical potential of proteasome inhibition. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2004.04.002
Vancouver
Anderson KC. The clinical potential of proteasome inhibition. European Journal of Cancer Supplements. 2004. doi:10.1016/j.ejcsup.2004.04.002
BibTeX
@article{Anderson2004,
author = {Anderson, Kenneth C.},
title = {The clinical potential of proteasome inhibition},
journal = {European Journal of Cancer Supplements},
year = {2004},
doi = {10.1016/j.ejcsup.2004.04.002}
}
EUVIMED